BR9712969A - Gel sensìvel à temperatura para distribuição sustentada de drogas de proteìnas - Google Patents
Gel sensìvel à temperatura para distribuição sustentada de drogas de proteìnasInfo
- Publication number
- BR9712969A BR9712969A BR9712969-0A BR9712969A BR9712969A BR 9712969 A BR9712969 A BR 9712969A BR 9712969 A BR9712969 A BR 9712969A BR 9712969 A BR9712969 A BR 9712969A
- Authority
- BR
- Brazil
- Prior art keywords
- drug delivery
- temperature sensitive
- protein drug
- sensitive gel
- sustained protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
"GEL SENSìVEL A TEMPERATURA PARA DISTRIBUIçãO SUSTENTADA DE DROGAS DE PROTEìNAS". Composições farmacêuticas para distribuição de proteínas farmacologicamente ativas são proporcionadas por esta invenção. As composições desta invenção compreendem uma matriz polimérica possuindo propriedades de gelificação térmica em que é incorporada uma discreta suspensão de pelo menos um polipeptídeo biologicamente ativo que retém mais de 90% de sua atividade biológica. Além do mais, a concentração de polipeptídeo macromolecular é maior do que 0,5% em peso da composição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/679,199 US5861174A (en) | 1996-07-12 | 1996-07-12 | Temperature sensitive gel for sustained delivery of protein drugs |
PCT/US1997/013479 WO1998002142A1 (en) | 1996-07-12 | 1997-07-11 | Temperature sensitive gel for sustained delivery of protein drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9712969A true BR9712969A (pt) | 2002-02-05 |
Family
ID=24725962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9712969-0A BR9712969A (pt) | 1996-07-12 | 1997-07-11 | Gel sensìvel à temperatura para distribuição sustentada de drogas de proteìnas |
Country Status (13)
Country | Link |
---|---|
US (2) | US5861174A (pt) |
EP (1) | EP0910342B1 (pt) |
JP (1) | JP2000514811A (pt) |
KR (1) | KR20000023751A (pt) |
CN (1) | CN1230108A (pt) |
AT (1) | ATE417601T1 (pt) |
AU (1) | AU3822497A (pt) |
BR (1) | BR9712969A (pt) |
CA (1) | CA2260967A1 (pt) |
DE (1) | DE69739169D1 (pt) |
ES (1) | ES2318860T3 (pt) |
IL (1) | IL127976A0 (pt) |
WO (1) | WO1998002142A1 (pt) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0955063A1 (de) * | 1998-04-01 | 1999-11-10 | Basf Aktiengesellschaft | Verwendung von wässrigen Zusammensetzungen in subkutanen oder intramuskulär zu verabreichenden Arzneimittel |
IL139030A0 (en) * | 1998-04-17 | 2001-11-25 | Angiogenix Inc | Therapeutic angiogenic factors and methods for their use |
AU769853B2 (en) | 1999-06-11 | 2004-02-05 | Atossa Genetics, Inc. | Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
WO2001010482A1 (en) * | 1999-08-05 | 2001-02-15 | Biocardia, Inc. | A system and method for delivering thermally sensitive and reverse-thermal gelation matrials |
AU2001276831A1 (en) * | 2000-06-22 | 2002-01-02 | Rxkinetix, Inc. | Delivery vehicle composition and methods for delivering antigens and other drugs |
AU2001273034A1 (en) | 2000-06-26 | 2002-01-08 | Rxkinetix, Inc. | Composition for delivery of hematopoietic growth factor |
US6685917B2 (en) * | 2000-11-22 | 2004-02-03 | Rxkinetix, Inc. | Treatment of mucositis |
US6565530B2 (en) | 2001-02-28 | 2003-05-20 | Scimed Life Systems, Inc. | Immobilizing objects in the body |
US20040185101A1 (en) * | 2001-03-27 | 2004-09-23 | Macromed, Incorporated. | Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
BR0210628A (pt) * | 2001-06-29 | 2004-08-10 | Becton Dickinson Co | Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula |
US6585997B2 (en) | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
US20060073174A1 (en) * | 2001-08-16 | 2006-04-06 | Access Pharmaceuticals, Inc. | Adherent and erodible film to treat a moist surface of a body tissue |
CN1604788B (zh) * | 2001-10-16 | 2013-04-17 | 里克斯金蒂克斯公司 | 高浓度蛋白制剂及其制备方法 |
CA2471403A1 (en) * | 2001-12-21 | 2003-07-10 | Gensci Orthobiologics, Inc. | End-capped polyalkylene glycols and compositions containing such compounds |
US7205337B2 (en) * | 2001-12-21 | 2007-04-17 | Isotis Orthobiologics, Inc. | End-capped polymers and compositions containing such compounds |
ATE391742T1 (de) * | 2002-02-15 | 2008-04-15 | Nektar Therapeutics Al Corp | Hydrolytisch abbaubare polyalkylenoxid-polymere |
US7649023B2 (en) * | 2002-06-11 | 2010-01-19 | Novartis Ag | Biodegradable block copolymeric compositions for drug delivery |
US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
DE10326152A1 (de) * | 2003-06-06 | 2005-01-05 | Aventis Pharma Deutschland Gmbh | Verfahren und Vorrichtung zur quantitativen Analyse von Lösungen und Dispersionen mittels Nahinfrarot-Spektroskopie |
US20050118261A1 (en) * | 2003-06-12 | 2005-06-02 | Oien Hal J. | Compositions and methods of administering doxepin to mucosal tissue |
JP2007516968A (ja) * | 2003-12-05 | 2007-06-28 | ベクトン・ディキンソン・アンド・カンパニー | 皮内コンパートメントにおける免疫応答を増強する方法、およびそれらの方法で有用な化合物 |
WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
US20060121055A1 (en) * | 2004-12-06 | 2006-06-08 | Becton, Dickinson And Company, Inc. | Compositions with enhanced immunogenicity |
EP1965787B1 (en) * | 2005-11-30 | 2013-04-10 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
US20070191816A1 (en) * | 2006-02-13 | 2007-08-16 | Boston Scientific Scimed, Inc. | Radio frequency induced drug elution |
WO2007104173A2 (de) * | 2006-03-10 | 2007-09-20 | Laboswiss Ag | Verfahren zum solubilisieren, dispergieren und stabilisieren von stoffen, nach dem verfahren hergestellte erzeugnisse sowie die verwendung derselben |
US8197499B2 (en) * | 2006-06-21 | 2012-06-12 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
CA2656179A1 (en) * | 2006-06-21 | 2007-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US8608760B2 (en) * | 2006-06-21 | 2013-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
EP2124556B1 (en) | 2006-10-09 | 2014-09-03 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
EP2152166A4 (en) * | 2007-04-27 | 2014-09-17 | Pluromed Inc | ULTRASOUND SAMPLE WITH TEMPERATURE AND TEMPERATURE SENSITIVE ADHESION COUPLING JOINT |
CN101450035B (zh) * | 2007-12-07 | 2010-09-29 | 福建医科大学附属协和医院 | 一种用于肿瘤局部消融治疗的双重缓释生物制剂 |
CA2710002A1 (en) * | 2007-12-20 | 2009-07-09 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
EP2240022B1 (en) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
JP5836593B2 (ja) * | 2008-02-29 | 2015-12-24 | プルーロームド インコーポレイテッドPluromed, Inc. | 感熱性ポリマーの加熱による局所塞栓 |
CA2721927C (en) | 2008-04-21 | 2014-01-28 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
AU2016228201A1 (en) * | 2008-04-21 | 2016-10-13 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
AU2009246870B2 (en) | 2008-05-14 | 2013-08-01 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
US8846770B2 (en) | 2008-06-18 | 2014-09-30 | Otonomy, Inc. | Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders |
WO2010011466A2 (en) | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
CA2731769C (en) | 2008-07-21 | 2013-09-10 | Otonomy, Inc. | Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
US8399018B2 (en) * | 2008-07-21 | 2013-03-19 | Otonomy, Inc. | Controlled release ion channel modulator compositions and methods for the treatment of otic disorders |
US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
EP2299979B1 (en) * | 2008-07-21 | 2020-11-25 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
US8563037B2 (en) * | 2009-02-06 | 2013-10-22 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
BRPI1008280A2 (pt) | 2009-02-24 | 2015-08-25 | Ritter Pharmaceuticals Inc | Formulações prebióticas e métodos mde uso |
EP3311667A1 (en) | 2009-07-08 | 2018-04-25 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
CN102770152B (zh) | 2009-11-25 | 2016-07-06 | 阿瑞斯根股份有限公司 | 肽类的粘膜递送 |
EP2521587B1 (en) * | 2010-01-08 | 2020-04-08 | Wake Forest University Health Sciences | Delivery system |
EP2563372A4 (en) | 2010-04-28 | 2013-10-02 | Ritter Pharmaceuticals Inc | PREBIOTIC FORMULATIONS AND METHODS OF USE |
US8642502B2 (en) | 2010-10-11 | 2014-02-04 | TRGel, LLC | Reversible gel-forming compositions for controlled delivery of bioactive substances |
CA2828705A1 (en) | 2011-03-07 | 2012-09-13 | Wake Forest University Health Sciences | Delivery system |
WO2012131678A1 (en) * | 2011-03-28 | 2012-10-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Sustained-release injectable formulation |
EA201690323A1 (ru) | 2013-08-27 | 2016-07-29 | Отономи, Инк. | Способы лечения заболеваний уха у детей |
EP3125905A4 (en) | 2014-04-04 | 2017-11-08 | Ritter Pharmaceuticals, Inc. | Methods and compositions for microbiome alteration |
JP6297180B2 (ja) | 2014-07-03 | 2018-03-20 | オトノミ—,インク. | シプロフロキサシン組成物の滅菌 |
US9987368B2 (en) * | 2015-03-17 | 2018-06-05 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising polypeptide |
CA3055170A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
EP3512513A4 (en) | 2016-09-16 | 2020-04-15 | Otonomy, Inc. | GEL FORMULA FOR THE EAR FOR TREATING OTITIS EXTERNA |
CA3088630A1 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
CA3111795A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
EP3986163A2 (en) | 2019-06-19 | 2022-04-27 | Solarea Bio, Inc. | Microbial compositions and methods for producing upgraded probiotic assemblages |
AU2022391767A1 (en) | 2021-11-22 | 2024-07-04 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188373A (en) * | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4100271A (en) * | 1976-02-26 | 1978-07-11 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
JPS5821691A (ja) * | 1981-07-29 | 1983-02-08 | Mochida Pharmaceut Co Ltd | α−及びβ−インタ−フェロンの精製方法 |
US5328695A (en) * | 1983-03-22 | 1994-07-12 | Massachusetts Institute Of Technology | Muscle morphogenic protein and use thereof |
US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
US4474753A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
US4478822A (en) * | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474752A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4702917A (en) * | 1985-11-18 | 1987-10-27 | Research Triangle Institute | Porous bioabsorbable polyesters |
US4954154A (en) * | 1986-03-26 | 1990-09-04 | The O. M. Scott & Sons Company | Controlled release fertilizer gel composition and process for its production |
US4962091A (en) * | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
US4895716A (en) * | 1987-06-09 | 1990-01-23 | Biogen, Inc. | Stabilized formulations of gamma interferons |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US5126141A (en) * | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
US5324519A (en) * | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
DE4002736A1 (de) * | 1990-01-31 | 1991-08-01 | Hoechst Ag | Biologisch abbaubare polymere, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe |
US5306501A (en) * | 1990-05-01 | 1994-04-26 | Mediventures, Inc. | Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
US5300295A (en) * | 1990-05-01 | 1994-04-05 | Mediventures, Inc. | Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
US5346703A (en) * | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
US5071644A (en) * | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
US5143731A (en) * | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
CA2044878C (en) * | 1990-08-07 | 2000-12-26 | Tacey X. Viegas | Thermally reversible and irreversible gels |
US5077033A (en) * | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
US5124151A (en) * | 1990-08-07 | 1992-06-23 | Mediventures Inc. | Drug delivery by injection with thermo-irreversible gels |
US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
US5468505A (en) * | 1992-02-28 | 1995-11-21 | Board Of Regents, The University Of Texas System | Local delivery of fibrinolysis enhancing agents |
IT1255460B (it) * | 1992-07-28 | 1995-11-02 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive |
FR2694559B1 (fr) * | 1992-08-06 | 1994-10-28 | Atta | Nouveaux dérivés amphiphiles d'aminoacides ou de peptides, leur procédé de préparation et leur utilisation dans des préparations à usage biomédical. |
ATE197550T1 (de) * | 1993-02-23 | 2000-12-15 | Genentech Inc | Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff |
US5420197A (en) * | 1994-01-13 | 1995-05-30 | Hydromer, Inc. | Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
US5554147A (en) * | 1994-02-01 | 1996-09-10 | Caphco, Inc. | Compositions and devices for controlled release of active ingredients |
-
1996
- 1996-07-12 US US08/679,199 patent/US5861174A/en not_active Expired - Lifetime
-
1997
- 1997-07-11 IL IL12797697A patent/IL127976A0/xx unknown
- 1997-07-11 WO PCT/US1997/013479 patent/WO1998002142A1/en not_active Application Discontinuation
- 1997-07-11 DE DE69739169T patent/DE69739169D1/de not_active Expired - Lifetime
- 1997-07-11 AU AU38224/97A patent/AU3822497A/en not_active Abandoned
- 1997-07-11 CA CA002260967A patent/CA2260967A1/en not_active Abandoned
- 1997-07-11 AT AT97935238T patent/ATE417601T1/de not_active IP Right Cessation
- 1997-07-11 BR BR9712969-0A patent/BR9712969A/pt not_active Application Discontinuation
- 1997-07-11 CN CN97197798A patent/CN1230108A/zh active Pending
- 1997-07-11 JP JP10506356A patent/JP2000514811A/ja active Pending
- 1997-07-11 ES ES97935238T patent/ES2318860T3/es not_active Expired - Lifetime
- 1997-07-11 EP EP97935238A patent/EP0910342B1/en not_active Expired - Lifetime
-
1999
- 1999-01-12 KR KR1019997000215A patent/KR20000023751A/ko not_active Application Discontinuation
- 1999-01-15 US US09/232,288 patent/US6482435B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5861174A (en) | 1999-01-19 |
ATE417601T1 (de) | 2009-01-15 |
CA2260967A1 (en) | 1998-01-22 |
ES2318860T3 (es) | 2009-05-01 |
US6482435B1 (en) | 2002-11-19 |
JP2000514811A (ja) | 2000-11-07 |
WO1998002142A1 (en) | 1998-01-22 |
IL127976A0 (en) | 1999-11-30 |
CN1230108A (zh) | 1999-09-29 |
EP0910342B1 (en) | 2008-12-17 |
EP0910342A1 (en) | 1999-04-28 |
AU3822497A (en) | 1998-02-09 |
DE69739169D1 (de) | 2009-01-29 |
KR20000023751A (ko) | 2000-04-25 |
EP0910342A4 (en) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712969A (pt) | Gel sensìvel à temperatura para distribuição sustentada de drogas de proteìnas | |
ATE195721T1 (de) | Lipopolyamine als transfectionsmittel und ihre pharmazeutischen anwendungen | |
ES2163444T3 (es) | Composiciones y metodos para la administracion oral de farmacos. | |
ATE342358T1 (de) | Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen | |
ES2094359T3 (es) | Formulaciones farmaceuticas de proteinas osteogenicas. | |
BR9914708A (pt) | Composição de matéria, dna, vetor de expressão, célula hospedeira, e, processo para preparar um composto farmacologicamente ativo | |
ATE187062T1 (de) | Formulierungen zum suspendieren: von proteine und peptiden | |
ATE179429T1 (de) | Cytokine dämpfende substanzen | |
BR9808965A (pt) | Composições comestìveis inluindo gel particulado | |
ATE369434T1 (de) | Adenoassoziierte virusvektoren und ihre verwendungen | |
RS49928B (sr) | Derivati eritropoetina | |
ATE327254T1 (de) | Interferon-beta fusionsproteine und deren verwendungen | |
PT749317E (pt) | Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade | |
MX9207334A (es) | Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene | |
DE69534165D1 (de) | Adenovirus mit glutathion peroxydate gene | |
ATE187740T1 (de) | Modifizierte proteine und peptide enthaltende pharmazeutische mittel | |
GR890100846A (el) | Μεθοδος μετατροπης κυτταρικης διαφοροποιησης και λειτουργιας καισυνθεσεις της. | |
IT1299583B1 (it) | Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica | |
DE59407457D1 (de) | Blockierung der anlagerung von keimen an menschliche zellen | |
ATE208369T1 (de) | Neue lipopolyamine, deren darstellung und anwendung | |
DE69533796D1 (de) | Für die glutamatabhängigen chloridkanäle kodierende dna | |
PT906272E (pt) | Peptidos | |
BR9811709A (pt) | Polipeptìdeos modificados com alta atividade e reduzida alergenicidade | |
BR9812138A (pt) | Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta | |
FR2719593B1 (fr) | Nouveaux polypeptides biologiquement actifs, leur préparation et composition pharmaceutique les contenant. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |